Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Black Diamond Therapeutics Inc (NQ: BDTX ) 5.950 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 5.950 Bid (Size) 4.920 (2) Ask (Size) 6.000 (5) Prev. Close 5.950 Today's Range 5.950 - 5.950 52wk Range 1.620 - 7.660 Shares Outstanding 36,213,654 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Tuesday's Intraday Session June 11, 2024 Via Benzinga Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting June 01, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Performance YTD +104.47% +104.47% 1 Month +8.78% +8.78% 3 Month +4.39% +4.39% 6 Month +117.95% +117.95% 1 Year +22.43% +22.43% More News Read More Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference May 29, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutic: Q4 Earnings Insights March 12, 2024 Via Benzinga BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session April 23, 2024 Via Benzinga Black Diamond Therapeutics Announces Changes to Board of Directors April 11, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting April 07, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Participate in Upcoming Investor Conferences April 03, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 12, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 March 05, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference February 28, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones January 04, 2024 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session December 13, 2023 Via Benzinga Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM December 13, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session December 08, 2023 Via Benzinga Black Diamond Therapeutics to Participate in Upcoming Investor Conferences November 07, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 06, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying October 20, 2023 Via Benzinga Topics Stocks Exposures US Equities Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535 October 14, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 04, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire 10 Health Care Stocks Whale Activity In Today's Session September 18, 2023 Via Benzinga Black Diamond Therapeutics Announces CEO Transition September 18, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.